What Is the Treatment of Primary Hypothyroidism with Ischemic Heart Disease or in Patients Over 60?
When primary hypothyroidism is diagnosed in a patient older than 60 years or with known or suspected ischemic heart disease, the treatment approach differs meaningfully from the standard protocol. Both situations call for careful management to avoid adverse effects from thyroid excess.
This protocol applies to patients with primary hypothyroidism who meet either of the following criteria: age older than 60 years, or known or suspected ischemic heart disease. Either condition modifies how thyroid hormone replacement is initiated and advanced.
Levothyroxine is the treatment used in this setting. For this specific population, initiation follows a modified strategy — starting at a conservatively low dose with gradual, stepwise titration rather than a standard full-replacement start. The complete regimen, titration schedule, and decision points are detailed in the full structured protocol.
Normalisation of thyroid-stimulating hormone (TSH) to the normal range: 0.4 to 4.5 mIU per L.
References
Patients older than 60 years or with known or suspected ischemic heart disease should start at a lower dosage of levothyroxine (12.5 to 50 mcg per day).
For older patients or those with coronary artery disease, levothyroxine therapy should be started at 25 to 50 mcg per day, with titration of 25 mcg every three to four weeks until a target dosage is achieved to decrease the potential for adverse effects from thyroid excess (e.g., atrial fibrillation, dysrhythmia, angina, osteoporosis).
In newly diagnosed patients with hypothyroidism who are older than 60 years or with known or suspected ischemic heart disease, levothyroxine therapy should be initiated at 12.5 to 50 mcg per day.
Increase dosage by 25 mcg every three to four weeks until TSH is in normal range.
View source ↗